Bid Publish Date
20-Dec-2024, 8:47 am
Bid End Date
10-Jan-2025, 9:00 am
EMD
₹18,000
Location
Progress
Quantity
88210
Category
ACENOCOUMAROL 2MG TAB
Bid Type
Two Packet Bid
Indian Army invites bids for ACENOCOUMAROL 2MG TAB, ALPRAZOLAM 025 MG TAB, BETHANECHOL 25 MG TAB, BICALUTAMIDE 50MG TAB, CHLORDIAZEPOXIDE 10 MG TAB, CLONAZEPAM 0. 5MG TAB, CYCLOSPORIN 100MG TAB, DEFERASIROX 400 MG TAB, DILTIAZEM 90MG SR TAB, EFAVIRENZ 600 MG TAB, ESCITALOPRAM 10MG TAB, FEXOFENADINE 120MG TAB, IMATINIB 400MG CAP, Influenza Vaccine, LEFLUNOMIDE 10 MG TAB, LEFLUNOMIDE 20 MG TAB, Levosalbutamol 50MCG Beclomethasone 50MCG Inhaler, LITHIUM CARBONATE 300 MG CAP and TAB, MERCAPTOPURINE TAB 50 mg, NINTEDANIB 100MG CAP, NINTEDANIB 150 MG CAP, NORTRIPTYLINE 10 MG TAB, PIRFENIDONE 200 MG, RANOLAZINE SR 500 MG TAB, RIVAROXABAN 2. 5 MG TAB, SODIUM VALPROATE 300 MG TAB, SUMATRIPTAN 50 MG TAB, SYP COUGH EXPECTORANT 100ML, TRAMADOL 50 MG CAP, ZOLPIDEM 10 MG TAB in JAMMU, JAMMU & KASHMIR. Quantity: 88210. Submission Deadline: 10-01-2025 09: 00: 00. Submit your proposal before the deadline.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
ACENOCOUMAROL 2MG TAB , ALPRAZOLAM 025 MG TAB , BETHANECHOL 25 MG TAB , BICALUTAMIDE 50MG TAB , CHLORDIAZEPOXIDE 10 MG TAB , CLONAZEPAM 0.5MG TAB , CYCLOSPORIN 100MG TAB , DEFERASIROX 400 MG TAB , DILTIAZEM 90MG SR TAB , EFAVIRENZ 600 MG TAB , ESCITALOPRAM 10MG TAB , FEXOFENADINE 120MG TAB , IMATINIB 400MG CAP , Influenza Vaccine , LEFLUNOMIDE 10 MG TAB , LEFLUNOMIDE 20 MG TAB , Levosalbutamol 50MCG Beclomethasone 50MCG Inhaler , LITHIUM CARBONATE 300 MG CAP and TAB , MERCAPTOPURINE TAB 50 mg , NINTEDANIB 100MG CAP , NINTEDANIB 150 MG CAP , NORTRIPTYLINE 10 MG TAB , PIRFENIDONE 200 MG , RANOLAZINE SR 500 MG TAB , RIVAROXABAN 2.5 MG TAB , SODIUM VALPROATE 300 MG TAB , SUMATRIPTAN 50 MG TAB , SYP COUGH EXPECTORANT 100ML , TRAMADOL 50 MG CAP , ZOLPIDEM 10 MG TAB
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
OTHER
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
ACENOCOUMAROL 2MG TAB
As per BOQ specification
ALPRAZOLAM 025 MG TAB
As per BOQ specification
BETHANECHOL 25 MG TAB
As per BOQ specification
BICALUTAMIDE 50MG TAB
As per BOQ specification
CHLORDIAZEPOXIDE 10 MG TAB
As per BOQ specification
CLONAZEPAM 0.5MG TAB
As per BOQ specification
CYCLOSPORIN 100MG TAB
As per BOQ specification
DEFERASIROX 400 MG TAB
As per BOQ specification
DILTIAZEM 90MG SR TAB
As per BOQ specification
EFAVIRENZ 600 MG TAB
As per BOQ specification
ESCITALOPRAM 10MG TAB
As per BOQ specification
FEXOFENADINE 120MG TAB
As per BOQ specification
IMATINIB 400MG CAP
As per BOQ specification
Influenza Vaccine
As per BOQ specification
LEFLUNOMIDE 10 MG TAB
As per BOQ specification
LEFLUNOMIDE 20 MG TAB
As per BOQ specification
Levosalbutamol 50MCG Beclomethasone 50MCG Inhaler
As per BOQ specification
LITHIUM CARBONATE 300 MG CAP and TAB
As per BOQ specification
MERCAPTOPURINE TAB 50 mg
As per BOQ specification
NINTEDANIB 100MG CAP
As per BOQ specification
NINTEDANIB 150 MG CAP
As per BOQ specification
NORTRIPTYLINE 10 MG TAB
As per BOQ specification
PIRFENIDONE 200 MG
As per BOQ specification
RANOLAZINE SR 500 MG TAB
As per BOQ specification
RIVAROXABAN 2.5 MG TAB
As per BOQ specification
SODIUM VALPROATE 300 MG TAB
As per BOQ specification
SUMATRIPTAN 50 MG TAB
As per BOQ specification
SYP COUGH EXPECTORANT 100ML
As per BOQ specification
TRAMADOL 50 MG CAP
As per BOQ specification
ZOLPIDEM 10 MG TAB
As per BOQ specification
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | ACENOCOUMAROL 2MG TAB | As per BOQ specification | 1,800 | no | dglp171gem | 30 | |
| 2 | ALPRAZOLAM 025 MG TAB | As per BOQ specification | 10,000 | no | dglp171gem | 30 | |
| 3 | BETHANECHOL 25 MG TAB | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 4 | BICALUTAMIDE 50MG TAB | As per BOQ specification | 300 | no | dglp171gem | 30 | |
| 5 | CHLORDIAZEPOXIDE 10 MG TAB | As per BOQ specification | 3,000 | no | dglp171gem | 30 | |
| 6 | CLONAZEPAM 0.5MG TAB | As per BOQ specification | 7,000 | no | dglp171gem | 30 | |
| 7 | CYCLOSPORIN 100MG TAB | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 8 | DEFERASIROX 400 MG TAB | As per BOQ specification | 1,200 | no | dglp171gem | 30 | |
| 9 | DILTIAZEM 90MG SR TAB | As per BOQ specification | 6,000 | no | dglp171gem | 30 | |
| 10 | EFAVIRENZ 600 MG TAB | As per BOQ specification | 300 | no | dglp171gem | 30 | |
| 11 | ESCITALOPRAM 10MG TAB | As per BOQ specification | 12,000 | no | dglp171gem | 30 | |
| 12 | FEXOFENADINE 120MG TAB | As per BOQ specification | 3,000 | no | dglp171gem | 30 | |
| 13 | IMATINIB 400MG CAP | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 14 | Influenza Vaccine | As per BOQ specification | 10 | no | dglp171gem | 30 | |
| 15 | LEFLUNOMIDE 10 MG TAB | As per BOQ specification | 2,400 | no | dglp171gem | 30 | |
| 16 | LEFLUNOMIDE 20 MG TAB | As per BOQ specification | 2,100 | no | dglp171gem | 30 | |
| 17 | Levosalbutamol 50MCG Beclomethasone 50MCG Inhaler | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 18 | LITHIUM CARBONATE 300 MG CAP and TAB | As per BOQ specification | 1,500 | no | dglp171gem | 30 | |
| 19 | MERCAPTOPURINE TAB 50 mg | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 20 | NINTEDANIB 100MG CAP | As per BOQ specification | 300 | no | dglp171gem | 30 | |
| 21 | NINTEDANIB 150 MG CAP | As per BOQ specification | 1,000 | no | dglp171gem | 30 | |
| 22 | NORTRIPTYLINE 10 MG TAB | As per BOQ specification | 12,000 | no | dglp171gem | 30 | |
| 23 | PIRFENIDONE 200 MG | As per BOQ specification | 600 | no | dglp171gem | 30 | |
| 24 | RANOLAZINE SR 500 MG TAB | As per BOQ specification | 7,200 | no | dglp171gem | 30 | |
| 25 | RIVAROXABAN 2.5 MG TAB | As per BOQ specification | 1,800 | no | dglp171gem | 30 | |
| 26 | SODIUM VALPROATE 300 MG TAB | As per BOQ specification | 2,000 | no | dglp171gem | 30 | |
| 27 | SUMATRIPTAN 50 MG TAB | As per BOQ specification | 200 | no | dglp171gem | 30 | |
| 28 | SYP COUGH EXPECTORANT 100ML | As per BOQ specification | 1,500 | bott | dglp171gem | 30 | |
| 29 | TRAMADOL 50 MG CAP | As per BOQ specification | 6,000 | no | dglp171gem | 30 | |
| 30 | ZOLPIDEM 10 MG TAB | As per BOQ specification | 2,000 | no | dglp171gem | 30 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | AMAR MEDICO Under PMA | - | 09-01-2025 12:43:24 | |
| 2 | ARORA BROS MEDILINKERS Under PMA | - | 09-01-2025 21:20:51 | |
| 3 | GANGA MEDICINE CENTRE Under PMA | - | 09-01-2025 20:21:17 | |
| 4 | SAVITRA MEDICOS PRIVATE LIMITED Under PMA | - | 09-01-2025 21:09:18 | |
| 5 | SIMAR ENTERPRISES Under PMA | - | 09-01-2025 20:28:48 | |
| 6 | SUNIL PHARMACY Under PMA | - | 09-01-2025 17:20:42 |
| Rank | Seller | Price | Item |
|---|---|---|---|
| L1 | ARORA BROS MEDILINKERS(MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : ACENOCOUMAROL 2MG TAB,ALPRAZOLAM 025 MG TAB,BETHANECHOL 25 MG TAB,BICALUTAMIDE 50MG TAB,CHLORDIAZEP | |
| L2 | GANGA MEDICINE CENTRE (MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : ACENOCOUMAROL 2MG TAB,ALPRAZOLAM 025 MG TAB,BETHANECHOL 25 MG TAB,BICALUTAMIDE 50MG TAB,CHLORDIAZEP | |
| L3 | SAVITRA MEDICOS PRIVATE LIMITED (MII) Under PMA | Item Categories : ACENOCOUMAROL 2MG TAB,ALPRAZOLAM 025 MG TAB,BETHANECHOL 25 MG TAB,BICALUTAMIDE 50MG TAB,CHLORDIAZEP |
Key insights about JAMMU AND KASHMIR tender market
The eligibility requirements include being a registered entity, maintaining an average annual turnover of ₹3 Lakh, and having at least 3 years of experience supplying to government or PSU entities. MSEs may be exempt from some criteria under existing policies.
Bidders must submit documents including experience criteria, past performance records, OEM authorization certificates, and compliance documentation as per the BoQ specification. Detailed submission guidelines are specified in the bid document.
To participate in the bidding process, interested entities must register on the GeM portal and ensure that they meet the eligibility criteria as defined. Details regarding the registration process can be obtained from the GeM website.
All documents must be uploaded in PDF or other specified formats as mentioned in the bid document. It is crucial that all files comply with the guidelines provided to avoid disqualification.
The products must adhere to specific technical specifications detailed within the tender documents. This guarantees that they meet quality and effectiveness standards required by the Department of Military Affairs.
Yes, all pharmaceuticals must meet the quality standards established by the Ministry of Defence. Bidders are required to present valid documentation to prove compliance with these standards.
Suppliers must satisfy both technical and financial compliance requirements as specified in the tender document. This includes certifications for product quality, proof of past performance, and maintaining the stipulated turnover.
Participants are required to submit an EMD of ₹18,000 along with their bid documents. Those seeking exemptions must provide valid supporting documents as outlined in the GeM guidelines.
A performance security that is 0.01% of the total bid price may be required, as specified in the tender documentation.
Payments will typically be made post-delivery and acceptance of the goods, following the completion of all necessary procedures as detailed in the tender criteria.
Bids will be evaluated based on total value-wise considerations, past performance records, adherence to specifications, and compliance with regulatory standards.
Bidders will be notified of results following the evaluation process, typically through communication on the GeM portal.
MSEs are eligible for exemptions regarding turnover and experience criteria, providing opportunities to participate based on their capability to meet quality standards.
Startups may also receive exemptions from specific criteria provided they meet quality standards, thereby encouraging their participation in the procurement process.
Procurement preferences are set for products meeting the local content criteria, promoting domestic manufacturing and supporting local suppliers in line with the 'Make in India' initiative.
Sign up now to access all documents
Main Document
OTHER
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS